There are, however, tumours that appear to have simply lost RUNX1 activity, so RUNX1 may be altered in a variety of ways, reflecting RUNX1’s role as a master regulator of cell fate, with ability to interact with various other transcription factors and chromatin modifiers35,36. The gene discussed is RUNX1; the disease is neoplasm.